Search for Clinical Trial Results
Langerhans Cell Histiocytosis - 28 Studies Found
Status | Study |
Recruiting |
Study Name: A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis Condition: Histiocytosis Date: 2017-04-11 Interventions:
|
Terminated |
Study Name: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer Condition:
|
Terminated |
Study Name: Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases Condition:
Interventions: |
Terminated |
Study Name: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer Condition:
|
RECRUITING |
Study Name: Mirdametinib in Histiocytic Disorders Condition: Langerhans Cell Histiocytosis (LCH) Date: 2024-05-19 Interventions: Mirdametinib is administered at a dose of 2 mg/m2, twice a day (BID) with a maximum dose of 4 mg BID on a continuous daily schedule.Consecu |
RECRUITING |
Study Name: LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study Condition: Langerhans Cell Histiocytosis Date: 2024-05-19 Interventions: Diagnostic and therapeutic data of adult patients with LCH, collected from clinical and laboratory evaluations, carried out during clinical practice. |
RECRUITING |
Study Name: LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study Condition: Langerhans Cell Histiocytosis Date: 2024-05-19 Interventions: Diagnostic and therapeutic data of adult patients with LCH, collected from clinical and laboratory evaluations, carried out during clinical practice. |